Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Clinical trial NCT05618327 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05618327
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-13
- Primary completion
- 2026-12-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.